PICKERING, ON, September 4, 2018 – Purdue Pharma (Canada) announces today that BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle launched on August 3, 2018.
BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle received market authorization by Health Canada in 2018 to help treat infections that can cause sore throats due to viruses and bacteria.
“We are very excited to be launching these truly innovative products for Canadians. One of the most common early symptoms of an upper respiratory tract infection is a sore throat, and we have developed BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle to help treat those viral and bacterial infections that cause sore throats. Now consumers can treat an oral infection from that very first throat tickle,” says Sheryl Willison, Senior Director, OTC Franchise, Purdue Pharma (Canada).
“Building on the legacy and the success of the Betadine brand around the world, we are proud to be able to introduce these new product offerings to Canadian consumers. BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle are both manufactured in Canada, in our state-of-the art pharmaceutical manufacturing facility located in Pickering, Ontario,” says John Sebben, VP of Manufacturing Operations, Purdue Pharma (Canada).
Purdue Pharma (Canada) has a well-established history of successfully bringing innovative medicines to Canadians, and is introducing these new products to the cough and cold medicines regimen.
BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle were approved by Health Canada to help treat viral, bacterial, or fungal infections of the mouth or throat, including infections that cause sore throat. They also help treat mouth ulcers (canker sores) and have been shown to kill viruses, bacteria, and fungi associated with oral thrush, as well as removing bacteria that causes bad breath. Please consult the Product Licence for BETADINE® Sore Throat Spray and BETADINE® Sore Throat Gargle for complete administration, contraindications and safety information.
About Purdue Pharma (Canada)
Purdue Pharma (Canada) is a research-based pharmaceutical and consumer healthcare company which has operated in Canada for over 60 years. Its 400 employees are committed to improving the health and quality of life of Canadians. The company has a broad portfolio of prescription and non-prescription medications including: prescription treatments for pain, ADHD, chemotherapy-induced nausea and vomiting (CINV), various ophthalmic conditions and OTC products. The company supports evidence-based education for the safe use of its products. Its headquarters, located in Pickering, ON, include integrated research & development, formulation and manufacturing operations. Privately held and founded by physicians, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma network of companies. Learn more at www.purdue.ca
Lisa Joyce, Head of Communications
Purdue Pharma (Canada)
Pickering, ON, Canada